Abstract
A 60-year-old man was referred to our hospital for the evaluation and treatment of general malaise. Contrast-enhanced computed tomography detected sigmoid colon cancer that had invaded the bladder, multiple liver metastases, and a small intestinal tumor. Hartmann's procedure was performed, with partial bladder and small bowel resection. A pathological examination revealed that the patient had sigmoid colon cancer and a gastrointestinal stromal tumor. The biopsy findings of a tumor in segment 8 of the liver indicated the presence of adenocarcinoma, thereby indicating the origin of multiple liver metastases from sigmoid colon cancer. On chemotherapy, the tumors in liver segments 2/3 and 8 shrank. However, the tumor in segment 6 enlarged. Since radical resection of all metastatic liver tumors was possible, hepatectomy was performed 10 months after the initial surgery. A pathological examination revealed that the tumors in segments 2/3, 4, and 8 were adenocarcinomas and the tumors in segments 4, 6, and 7 had originated from the gastrointestinal stromal tumor. This suggested the coexistence of liver metastases from sigmoid colon cancer and the gastrointestinal stromal tumor. In cases involving multiple primary tumors, it is necessary to consider the possible coexistence of multiple metastases from different primary tumors.
Similar content being viewed by others
References
Miettinen M, Lasota J. Gastrointestinal stromal tumors–definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch. 2001;438:1–12.
Vassos N, Agaimy A, Hohenberger W, et al. Coexistence of gastrointestinal stromal tumours (GIST) and malignant neoplasms of different origin: prognostic implications. Int J Surg. 2014;12:371–7.
Japanese Classification of Colorectal, Appendiceal, and Anal Carcinoma. 9th ed. Tokyo: Kanehara;2019.
Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol. 2006;23:70–83.
Søreide K, Sandvik OM, Søreide JA, et al. Global epidemiology of gastrointestinal stromal tumours (GIST): A systematic review of population-based cohort studies. Cancer Epidemiol. 2016;40:39–46.
Hirota S, Isozaki K. Pathology of gastrointestinal stromal tumors. Pathol Int. 2006;56:1–9.
Takazawa Y, Sakurai S, Sakuma Y, et al. Gastrointestinal stromal tumors of neurofibromatosis type I (von Recklinghausen’s disease). Am J Surg Pathol. 2005;29:755–63.
Carney J. Carney Triad. In: Stratakis C, editor. Endocrine tumor syndromes and their genetics. Basel: Kargar; 2013. p. 92–110.
Li FP, Fletcher JA, Heinrich MC, et al. Familial gastrointestinal stromal tumor syndrome: phenotypic and molecular features in a kindred. J Clin Oncol. 2005;23:2735–43.
Agaimy A, Wuensch PH. Gastrointestinal stromal tumours in patients with other-type cancer: a mere coincidence or an etiological association? A study of 97 GIST cases. Z Gastroenterol. 2005;43:1025–30.
Kalmár K, Tornóczky T, Pótó L, et al. Gastrointestinal stromal tumours in a single institute: is there an association to other gastrointestinal malignancies? Magy Seb. 2004;57:251–6.
Waidhauser J, Bornemann A, Trepel M, et al. Frequency, localization, and types of gastrointestinal stromal tumor-associated neoplasia. World J Gastroenterol. 2019;25:4261–77.
Kanematsu M, Hondo H, Goshima S, et al. Imaging liver metastases: review and update. Eur J Radiol. 2006;58:217–8.
Bressler EL, Alpern MB, Glazer GM, et al. Hypervascular hepatic metastases: CT evaluation. Radiology. 1987;162:49–51.
Aoki H, Arata T, Utsumi M, et al. Synchronous coexistence of liver metastases from cecal leiomyosarcoma and rectal adenocarcinoma: a case report. World J Gastroenterol. 2017;23:1725–34.
Kumar K, Rowsell C, Law C, et al. Coexistence of gastrointestinal stromal tumor and colorectal adenocarcinoma: two case reports. J Gastrointest Oncol. 2011;2:50–4.
Scripture CD, Figg WD. Drug interactions in cancer therapy. Nat Rev Cancer. 2006;6:546–58.
Artinyan A, Kim J, Soriano P, et al. Metastatic gastrointestinal stromal tumors in the era of imatinib: improved survival and elimination of socioeconomic survival disparities. Cancer Epidemiol Biomarkers Prev. 2008;17:2194–201.
Phan K, Martires K, Kurlander D, et al. The incidence of second primary malignancies after gastrointestinal stromal tumor before and after the introduction of imatinib mesylate. Transl Cancer Res. 2014;3:152–9.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by SK and MM. The first draft of the manuscript was written by SK, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Human rights
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
Informed consent was obtained from the patient in this reported case.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kato, S., Miyo, M., Kato, T. et al. Coexistence of multiple liver metastases from sigmoid colon cancer and a gastrointestinal stromal tumor in the small intestine. Clin J Gastroenterol 15, 117–122 (2022). https://doi.org/10.1007/s12328-021-01556-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12328-021-01556-7